| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.9B | $11.3B | $9.9B | $8.6B | $7.5B | $1.6B | $1.4B | $1.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.9B | $1.9B | $1.6B | $1.2B | $0.8B | $0.1B | $0.1B | $0.0B |
| Net Income | $1.5B | $1.5B | $1.2B | $0.9B | $0.7B | $0.2B | $0.1B | $0.0B |
| EPS (Basic) | $1.15 | $1.12 | $44.59 | $32.28 | $23.21 | $6.82 | $2.61 | $1.15 |
| EPS (Diluted) | $1.14 | $1.11 | $44.34 | $32.04 | $22.90 | $6.69 | $2.55 | $1.15 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.0B | $9.2B | $8.0B | $6.9B | $6.7B | $6.0B | $5.1B | $2.3B |
| Current Assets | $1.5B | $1.8B | $1.6B | $1.2B | $1.4B | $1.4B | $1.1B | $0.8B |
| Cash & Equivalents | $0.4B | $0.7B | $0.6B | $0.4B | $0.8B | $0.6B | $0.5B | $0.2B |
| Total Liabilities | $6.2B | $5.5B | $5.0B | $4.6B | $4.4B | $4.0B | $3.4B | $0.8B |
| Current Liabilities | $1.2B | $1.2B | $1.0B | $0.9B | $0.9B | $0.8B | $0.7B | $0.4B |
| Stockholders' Equity | $2.8B | $3.7B | $3.1B | $2.4B | $2.3B | $2.0B | $1.7B | $1.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.1B | $2.1B | $1.8B | $1.3B | $1.3B | $0.7B | $0.7B | $0.6B |
| Investing Cash Flow | $-0.0B | $-0.8B | $-0.9B | $-0.8B | $-0.5B | $-0.4B | $-0.3B | $-0.4B |
| Capital Expenditures | $0.7B | $0.6B | $0.6B | $0.5B | $0.4B | $0.4B | $0.3B | $0.3B |
| Financing Cash Flow | $-2.5B | $-1.1B | $-0.7B | $-0.9B | $-0.5B | $-0.1B | $-0.2B | $-0.2B |